Claude for Healthcare adds medical database connectors and prior authorization capabilities, while life sciences features expand to clinical trial management.
Anthropic has launched Claude for Healthcare, a HIPAA-ready AI platform designed for healthcare providers, payers, and health technology companies, alongside expanded capabilities for its existing Claude for Life Sciences offering.
The new healthcare platform includes direct connectors to industry-standard databases including the Centers for Medicare & Medicaid Services Coverage Database, the International Classification of Diseases 10th Revision, and the National Provider Identifier Registry. These integrations allow healthcare organizations to automate tasks such as prior authorization reviews, claims appeals, and care coordination through the AI system, according to a company announcement.
“These tools can be used to speed up prior authorization requests so that patients can get life-saving care more quickly, can help with patient care coordination to reduce the pressures on clinicians’ time, and help with regulatory submissions so that more life-saving drugs can come to market faster,” according to the company’s announcement.
Performance Improvements Drive Real-World Applications
The platform runs on Claude Opus 4.5, Anthropic’s latest model, which the company says shows significant improvements in medical benchmark performance. On MedCalc medical calculation accuracy tests, the model achieved substantial gains over previous versions, while MedAgentBench evaluations from Stanford showed improved medical agent task completion rates.
The healthcare platform includes two new Agent Skills: FHIR development tools for healthcare system interoperability and a customizable prior authorization review template. The prior authorization feature can cross-reference coverage requirements, clinical guidelines, patient records, and appeal documents to propose determinations for payer review.
Personal Health Data Integration
Claude Pro and Max subscribers in the US can now connect their personal health records through new integrations with HealthEx, Function, Apple Health, and Android Health Connect. The platform can summarize medical histories, explain test results, and help users prepare questions for medical appointments.
The company emphasizes that health data integrations are private by design, with users controlling exactly what information they share. Anthropic states it does not use personal health data to train its models.
Life Sciences Capabilities Expand to Clinical Trials
The expanded Claude for Life Sciences now includes connectors to clinical trial management platforms including Medidata for study feasibility data, ClinicalTrials.gov for trial registry information, and bioRxiv & medRxiv for preprint research access.
Additional scientific platform integrations include ToolUniverse’s library of over 600 scientific tools, Open Targets for drug target identification, ChEMBL bioactive compound database, and Owkin’s Pathology Explorer for tissue image analysis.
New Agent Skills support clinical trial protocol drafting, regulatory submission preparation, and bioinformatics workflows. The clinical trial protocol feature incorporates FDA and NIH requirements along with organization-specific templates and datasets.
Industry Partnerships and Availability
Anthropic is partnering with consulting firms including Accenture, Deloitte, KPMG, and PwC to help organizations implement the AI tools. The platform is available across AWS, Google Cloud, and Microsoft Azure.
The new healthcare and life sciences features are available to all Claude subscribers, including Pro, Max, Teams, and Enterprise plans. Organizations can contact Anthropic’s sales team for enterprise implementations.
The announcement comes as healthcare organizations increasingly seek AI solutions for administrative tasks and clinical decision support, with particular focus on reducing documentation burden and improving operational efficiency.
ID 375360613 @ Alina Vytiuk | Dreamstime.com